Supravalvular aortic stenosis (SVAS) was first systematically described in 1961 when Williams et al. reported a syndrome characterized by unusual elfin facies, hypercalcemia, mental retardation and aortic stenosis. In the same year Beuren et al. also described a similar group of cases, and this syndrome is known today as Williams-Beuren syndrome (WBS).
The genetic basis was revealed in 1993–1994. A microdeletion of about 1.5–1.8 Mb at chromosome 7q11.23 including the elastin (ELN) gene was identified as the cause of WBS. It was subsequently shown that isolated SVAS (nonsyndromic) arises from a point mutation or isolated deletion of the ELN gene.
Surgical treatment developed after McGoon and Edwards performed the first successful corrective operation in 1961. Various enlargement aortoplasties (patch aortoplasty, three-patch technique, pantaloon patch, etc.) were developed, and surgical results steadily improved. Early surgery is now established as the standard treatment, and evaluation for coexisting coronary stenosis is an essential preoperative step.
2. Causes
The main cause of SVAS is an abnormality of the elastin (ELN) gene. Elastin is a protein essential for forming the elastic fibers of the aortic wall and plays a key role in maintaining vascular elasticity and structural integrity.
Syndromic SVAS (Williams-Beuren syndrome): Caused by a microdeletion of about 1.5–1.8 Mb at chromosome 7q11.23, in which about 25–28 genes including the ELN gene are deleted simultaneously. This causes haploinsufficiency, reducing elastin protein production.
Isolated SVAS (nonsyndromic): Caused by point mutations (missense, nonsense, splice site) or small insertions/deletions of the ELN gene. It shows an autosomal dominant inheritance pattern, and familial occurrence is possible.
Because of elastin haploinsufficiency, formation of elastic fibers in the aortic wall decreases, and compensatory proliferation of smooth muscle cells and collagen deposition increase. As a result, a thickened fibromuscular ring forms in the ascending aorta (mainly the supravalvular ridge, just above the sinotubular junction), causing stenosis.
Because the coronary ostia lie distal (inside) to the stenosis, coronary perfusion is exposed to high pressure, and as the stenosis progresses the coronary ostia themselves may also become stenotic, so the risk of ischemia is high.
3. Genetics
The genetics of SVAS is divided into syndromic and nonsyndromic:
Williams-Beuren syndrome (WBS):
Chromosome 7q11.23 microdeletion (~1.55 Mb): arises from unequal crossover between LCRs (low copy repeats)
Incidence: 1 in 7,500–10,000
Mostly de novo mutations; rarely inherited from one parent
Deleted genes: ~25 genes including ELN (elastin), LIMK1 (cognitive function), GTF2I and GTF2IRD1
Traits: distinctive facies (elfin facies: broad forehead, short nose, full lips), cardiovascular abnormalities (SVAS ~80%), intellectual disability (mild to moderate), hypersocial personality, infantile hypercalcemia, renal abnormalities
Nonsyndromic isolated SVAS:
Single point mutation or small deletion of the ELN gene (7q11.23)
Autosomal dominant inheritance; when familial, appears across multiple generations
High penetrance; variable expressivity
Diagnosis is made by confirming the 7q11.23 deletion with FISH, chromosomal microarray (CMA) or MLPA, or by confirming point mutations with ELN gene sequencing. When WBS is suspected, CMA is recommended as the first-line test.
4. General epidemiology
SVAS is the rarest form of congenital aortic stenosis, accounting for about 5–8% of all congenital aortic stenosis. It is much rarer than valvular aortic stenosis (~75%) and subvalvular stenosis (~20%).
The incidence of WBS is reported as 1 in 7,500–20,000, and in Korea several dozen cases are diagnosed per year. Cardiovascular abnormalities accompany about 70–80% of WBS patients, and among them SVAS is the most common (~80%). Peripheral pulmonary artery stenosis is also commonly associated (~75%).
Isolated (nonsyndromic) SVAS is very rare, and accurate incidence statistics are lacking. Familial cases present with a completely different clinical picture (no intellectual disability, no distinctive facies), so differential diagnosis is necessary.
As for sex distribution, WBS itself is equal in men and women, and there is no marked sex difference in isolated SVAS either. It can be registered under Special Copayment Reduction V272 in Korea and is eligible for rare disease support.
5. Pathophysiology
The pathogenesis of SVAS begins with haploinsufficiency of the elastin protein. The normal aortic wall has a repeating structure of elastic lamellae in the media, with smooth muscle cells arranged between the lamellae. When elastin synthesis decreases, the following process occurs in a cascade:
Decreased number of elastic lamellae and abnormal elastin fiber formation
Compensatory proliferation and migration of smooth muscle cells
The stenosis mainly takes the form of thickening of the aortic valve ridge at the level of the aortic valve commissures, and is most common at the sinotubular junction above the sinus of Valsalva. In severe cases, diffuse lesions may appear involving the entire aorta or even the pulmonary artery branches (diffuse SVAS).
Abnormal coronary perfusion: Because the coronary ostia lie distal (medial) to the stenosis, they are exposed to high-pressure blood flow during systole. This causes early fibrosis and stenosis of the coronary artery wall and is a cause of myocardial ischemia and sudden death. Both the left and right coronary ostia may become stenotic, which is clinically very dangerous.
6. Symptoms
The symptoms of SVAS vary according to the degree of stenosis, coronary involvement and the presence of WBS.
Cardiovascular symptoms:
Exertional chest pain: symptoms of myocardial ischemia due to reduced coronary perfusion. In young children it may be expressed as irritability and feeding refusal.
Syncope or presyncope: occurs during or immediately after exercise. It may be a warning symptom of sudden death and requires emergency management.
Heart failure symptoms: fatigue, exercise intolerance, dyspnea. Occur in severe stenosis.
Sudden cardiac death: risk is high with severe bilateral coronary ostial stenosis. The risk of occurring during exercise is particularly high.
Non-cardiovascular symptoms associated with WBS:
Intellectual disability (mean IQ 55–65): language ability relatively preserved but visuospatial cognition reduced
Hypersocial personality (hypersociability): friendly even toward strangers
Musical talent: excellent auditory memory and musical sensitivity
Systolic ejection murmur: best heard at the right upper sternal border, radiating to the neck. Quality and intensity vary with the degree of stenosis.
Upper limb blood pressure asymmetry: blood pressure in the right arm may be measured higher than in the left (because of the Coanda effect, blood flow after the stenosis is directed toward the right innominate artery). Conversely, the left may be lower, so measurement of blood pressure in both arms is necessary.
Carotid thrill: vibration may be palpated in the neck.
Apical impulse: forceful and sustained owing to left ventricular hypertrophy.
WBS-specific facial findings (elfin facies):
Broad forehead, periorbital fullness
Short, upturned nose, broad nasal tip
Full lips, wide mouth
Stellate iris pattern: especially prominent in blue eyes
Other findings: Joint hyperlaxity, low muscle tone, short stature.
8. Screening
Screening for SVAS and WBS:
Clinical screening:
Suspect WBS in children with feeding problems, distinctive facies and developmental delay, and perform genetic testing.
When a heart murmur is found, perform echocardiography immediately.
In patients with a history of exertional chest pain or syncope, first evaluate the degree of stenosis and coronary involvement.
Genetic screening:
FISH (fluorescence in situ hybridization): has been used as the first-line test for the 7q11.23 deletion, but chromosomal microarray (CMA) is now more sensitive and comprehensive.
MLPA (multiplex ligation-dependent probe amplification): useful for detecting deletions/duplications of the ELN gene.
ELN gene sequencing: confirms point mutations in isolated SVAS or familial SVAS.
Prenatal screening:
Consider prenatal CMA testing when fetal echocardiography shows aortic abnormalities.
Prenatal diagnosis is recommended when one parent has WBS or isolated SVAS.
Family screening: When isolated SVAS is diagnosed, perform cardiac and genetic testing of first-degree relatives.
9. Diagnosis
The diagnosis of SVAS uses clinical evaluation, echocardiography, imaging studies and genetic testing in combination.
Echocardiography:
The primary diagnostic tool for SVAS. Evaluates the anatomy of the stenotic site (localized/diffuse), pressure gradient (Doppler peak velocity and pressure gradient), and left ventricular size and function.
Evaluates for coronary ostial stenosis (using transesophageal echocardiography or high-resolution pediatric echocardiography).
Also checks for coexisting peripheral pulmonary artery stenosis.
Cardiovascular CT angiography (CTA) and cardiac MRI:
Comprehensively evaluate the three-dimensional anatomy of the stenotic site, the origin and course of the coronary arteries, and abnormalities of peripheral pulmonary artery branches.
Essential for preoperative planning.
Cardiac catheterization and coronary angiography:
Used for hemodynamic evaluation (measurement of pressure gradient), accurate evaluation of coronary ostial stenosis, and intervention for peripheral pulmonary artery lesions.
Performed before surgery when a coronary abnormality is suspected.
Genetic testing:
Suspected WBS: confirm the 7q11.23 deletion by chromosomal microarray (CMA) or FISH.
Isolated SVAS: ELN gene sequencing and MLPA.
Exercise stress test: Useful for evaluating the degree of stenosis, exercise-induced symptoms and blood pressure response, but caution is required when coronary stenosis is present.
10. Treatment
Treatment of SVAS is determined by the degree of stenosis and coronary involvement.
Coronary ostial stenosis (indication regardless of degree)
Decreased left ventricular function, stenosis causing symptoms (chest pain, syncope)
Surgical methods:
Single-patch aortoplasty: A patch is inserted at the stenotic site to enlarge it. The most basic technique.
Three-patch technique (Doty technique): Enlarges all three sinuses of Valsalva to reconstruct a more physiological aortic shape. Excellent long-term results have been reported.
Inverted pantaloon patch (Inverted pantaloon/Myers-Waldhausen): Enlarges the main aorta and the sinuses of Valsalva simultaneously.
Management of coronary ostia: When coronary ostial stenosis coexists, coronary ostial plasty or coronary artery bypass grafting is performed concurrently.
Intervention for peripheral pulmonary artery stenosis: Balloon dilation or stent placement. For distal pulmonary artery branches where surgical intervention is difficult, interventional procedures are the main treatment option.
WBS multidisciplinary care:
A multidisciplinary team approach is needed, including cardiology (surgery, follow-up), developmental pediatrics (cognitive rehabilitation), endocrinology (hypercalcemia, thyroid), nephrology, ophthalmology, speech therapy and special education specialists.
In WBS patients, attention must be paid to general anesthesia complications during surgery (hyperexcitability, airway hyperreactivity).
11. Prognosis
The surgical prognosis of SVAS depends greatly on whether the coronary arteries are involved.
Surgical results:
Surgical mortality: ~1–3% without coronary involvement, 5–10% or more with coronary involvement
10-year survival: ~90% or higher (when coronary arteries are normal)
Reoperation rate: 10–20% (mainly residual stenosis or restenosis)
Problems in long-term follow-up:
Residual or recurrent SVAS: restenosis with growth
Coronary artery disease: coronary stenosis may progress even after surgery. Regular evaluation is needed
Peripheral pulmonary artery stenosis: continued follow-up and repeated intervention are needed
Aortic regurgitation: may occur after patch aortoplasty
Prognosis of WBS in adults:
Shortened life expectancy (mean ~57 years): mainly due to cardiovascular and renal complications
Hypertension: occurs in ~50% of adults with WBS. Related to decreased vascular elasticity and renal artery stenosis
Most adults have difficulty living independently and need continuous support
Social participation and vocational rehabilitation: shows excellent adaptability in simple, repetitive tasks
12. Prevention
Prevention of SVAS focuses on early detection and prevention of sudden death rather than prevention of occurrence.
Genetic counseling and family screening:
When WBS is diagnosed, parental FISH/CMA testing is performed to confirm the presence of germline mosaicism or a balanced translocation (mostly de novo mutations but rarely inherited from a parent).
Isolated SVAS (ELN variants) is inherited in an autosomal dominant manner, with a 50% risk for siblings and children, so family screening is important.
Prenatal diagnosis (fetal echocardiography, prenatal CMA/genetic testing) is recommended for the next pregnancy.
Prevention of sudden death:
Restrict participation in competitive sports when there is severe stenosis or coronary involvement.
When coronary stenosis is confirmed, perform surgical intervention as early as possible to lower the risk of sudden death.
During general anesthesia, the drop in blood pressure from inhalational anesthetics can be abrupt, so prior consultation with an anesthesiologist is needed.
Regular follow-up:
Before surgery: echocardiography every 6–12 months, cardiac catheterization if needed
After surgery: echocardiography and ECG at the first 6 months and then annually. Continued management at an adult congenital heart disease clinic after transition to adult care.
Patients with WBS have blood pressure, renal function and calcium levels monitored regularly.
Ewart AK, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5(1):11-16. PMID:8220421
Stamm C, et al. Surgical treatment of supravalvular aortic stenosis: do we need more than one patch? J Thorac Cardiovasc Surg. 1999;118(2):252-261. PMID:10423997
Wessel A, et al. Long-term follow-up in supravalvular aortic stenosis. Eur J Pediatr. 1994;153(11):871-876. PMID:7843227
Collins RT 2nd, et al. Cardiovascular disease in Williams syndrome. Circulation. 2013;127(21):2125-2134. PMID:23690465
Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239-252. PMID:20089974
Kruzliak P, et al. Supravalvular aortic stenosis: 36 years of surgical experience with different techniques of repair. Heart Surg Forum. 2013;16(5):E283-288. PMID:24163071
Bruno E, et al. Cardiovascular findings, and clinical course, in patients with Williams syndrome: a 27-year experience from a single centre. Cardiol Young. 2003;13(3):273-282. PMID:12903797
Zalzstein E, et al. Spectrum of cardiovascular lesions in supravalvular aortic stenosis: from familial to Williams-Beuren syndrome. Herz. 2003;28(8):673-679. PMID:14669038
Kau T, et al. Supravalvular aortic stenosis: CT angiographic findings and surgical correlation. AJR Am J Roentgenol. 2009;193(4):W344-348. PMID:19770338